1. Home
  2. BMRN vs ARE Comparison

BMRN vs ARE Comparison

Compare BMRN & ARE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BMRN
  • ARE
  • Stock Information
  • Founded
  • BMRN 1996
  • ARE 1994
  • Country
  • BMRN United States
  • ARE United States
  • Employees
  • BMRN N/A
  • ARE N/A
  • Industry
  • BMRN Biotechnology: Pharmaceutical Preparations
  • ARE Real Estate Investment Trusts
  • Sector
  • BMRN Health Care
  • ARE Real Estate
  • Exchange
  • BMRN Nasdaq
  • ARE Nasdaq
  • Market Cap
  • BMRN 12.1B
  • ARE 12.6B
  • IPO Year
  • BMRN 1999
  • ARE 1997
  • Fundamental
  • Price
  • BMRN $54.97
  • ARE $72.60
  • Analyst Decision
  • BMRN Buy
  • ARE Hold
  • Analyst Count
  • BMRN 22
  • ARE 9
  • Target Price
  • BMRN $93.43
  • ARE $117.11
  • AVG Volume (30 Days)
  • BMRN 2.2M
  • ARE 1.7M
  • Earning Date
  • BMRN 08-04-2025
  • ARE 07-21-2025
  • Dividend Yield
  • BMRN N/A
  • ARE 7.27%
  • EPS Growth
  • BMRN 152.82
  • ARE N/A
  • EPS
  • BMRN 2.71
  • ARE 0.76
  • Revenue
  • BMRN $2,950,227,000.00
  • ARE $3,111,841,000.00
  • Revenue This Year
  • BMRN $12.23
  • ARE N/A
  • Revenue Next Year
  • BMRN $9.99
  • ARE $2.72
  • P/E Ratio
  • BMRN $20.28
  • ARE $95.24
  • Revenue Growth
  • BMRN 19.36
  • ARE 5.31
  • 52 Week Low
  • BMRN $52.93
  • ARE $67.37
  • 52 Week High
  • BMRN $94.85
  • ARE $130.14
  • Technical
  • Relative Strength Index (RSI)
  • BMRN 40.74
  • ARE 49.53
  • Support Level
  • BMRN $53.76
  • ARE $70.83
  • Resistance Level
  • BMRN $56.25
  • ARE $75.80
  • Average True Range (ATR)
  • BMRN 1.26
  • ARE 1.66
  • MACD
  • BMRN 0.06
  • ARE 0.33
  • Stochastic Oscillator
  • BMRN 28.09
  • ARE 35.61

About BMRN BioMarin Pharmaceutical Inc.

BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments aimed at addressing complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria (PKU), hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development.

About ARE Alexandria Real Estate Equities Inc.

Alexandria Real Estate Equities Inc is an urban office real estate investment trust (REIT). It is engaged in the business of providing space for lease to life science, agtech, and technology tenants. The company has established a market presence in key locations, including Greater Boston, the San Francisco Bay Area, New York City, San Diego, Seattle, Maryland, and Research Triangle, Texas, and Canada. The Company is a life science real estate investment trust focused on developing, redeveloping, and operating properties that provide space for lease to tenants in the life science industry.

Share on Social Networks: